The D 2 -like dopamine receptors couple to a variety of signal transduction pathways, including inhibition of adenylate cyclase, mitogenesis, and activation of potassium channels. Although these effects are mediated via pertussis toxin-sensitive G proteins, G i/o , it is likely that some of these effects are influenced by the release of G protein ␤␥ subunits. Type II adenylate cyclase (ACII) is highly regulated by multiple biochemical stimuli, including protein kinase C, forskolin, G protein ␣ subunits, and G protein ␤␥ subunits. The ability of ␤␥ subunits to activate this enzyme in the presence of activated ␣ s has been particularly well characterized. Although stimulation by ␤␥ subunits has been described as conditional on the presence of activated ␣ s , ␤␥ subunits also potentiate ACII activity after activation of protein kinase C. We created stable cell lines expressing ACII and the D 2L receptor, the D 3 receptor, or the 1 On the other hand, D 2 , D 3 , and D 4 receptors all activate K ϩ channels in Xenopus laevis oocytes and stimulate mitogenesis in Chinese hamster ovary cells in a pertussis toxin-sensitive manner (3, 6). Thus, all D 2 -like receptors couple to pertussis toxin-sensitive pathways, but the efficiency and specificity of coupling are not identical for all subtypes.
We propose that activation of both D 2L and D 4.4 dopamine receptors potentiated phorbol-12-myristate-13-acetate-stimulated ACII activity through the release of ␤␥ subunits from pertussis toxin-sensitive G proteins. In contrast, the lack of D 3 receptor-mediated effects suggests that stimulation of D 3 receptors does not result in an appreciable release of ␤␥ subunits.
The D 2 -like receptor family is composed of D 2 , D 3 ,and D 4 dopamine receptors, which share considerable amino acid homology and generally have high affinity for butyrophenone and benzamide ligands. The most striking differences observed among these receptors are found in their ability to activate pertussis toxin-sensitive signaling events. For example, D 2 and D 3 receptors inhibit dopamine synthesis in a dopamine-producing cell line, whereas D 4 receptors do not (1, 2) , and D 2 and D 4 receptors mediate robust inhibition of cAMP accumulation in a variety of cell lines, whereas inhibition of cAMP accumulation by the D 3 receptor is modest or absent (2) (3) (4) (5) . 1 On the other hand, D 2 , D 3 , and D 4 receptors all activate K ϩ channels in Xenopus laevis oocytes and stimulate mitogenesis in Chinese hamster ovary cells in a pertussis toxin-sensitive manner (3, 6) . Thus, all D 2 -like receptors couple to pertussis toxin-sensitive pathways, but the efficiency and specificity of coupling are not identical for all subtypes.
ACII is widely expressed in the central nervous system, and its activity is regulated by a variety of biochemical signals (7) (8) (9) . Although ACII is not inhibited by G␣ i (10) , it is stimulated by ␣ s (11) , phorbol esters (12) , and G protein ␤␥ subunits (13) in reconstituted systems. Additionally, ACII is synergistically activated by ␣ s and PMA (8, 12) as well as by ␣ s and ␤␥ subunits (11, 13, 14) . In intact cells, ACII is activated by ␤␥ subunits in combination with activated ␣ s , whereas ␤␥ stimulation alone has no detectable effect on ACII activity (7, 9, (15) (16) (17) . In those studies ␤␥ subunits were supplied by stimulating G i/o -coupled receptors (e.g., the D 2 dopamine receptor), and activated ␣ s was provided by stimulating G s -coupled receptors or by co-transfection with a constitutively active mutant of ␣ s , ␣ s -Q227L. The synergy between activated ␣ s and either PMA or G protein ␤␥ subunits has led to ACII being described as a coincidence detector that integrates multiple signals (8, 18) . Further, liberation of ␤␥ subunits via activation of G i/o -coupled receptors enhances ACII stimulation by G q -coupled receptors or phorbol esters (19) .
The divergent signaling pathways of the D 2 -like dopamine receptors and the unique regulatory properties of ACII provide the basis for the current study. We examined and compared the ability of D 2 (15 g) with pBabe Puro (2 g), to confer resistance to puromycin (20) . Transfectants were isolated and screened by radioligand binding as described previously (21) . Creation of ACII/ D2L, ACII/D3, and ACII/D4 cells, was carried out by transfection of HEK-ACII cells with pcDNA1-D 2L , pcDNA1-D 3 , or pcDNA1-D 4.4 as described above.
Cell culture. HEK 293 cells expressing D 2 -like receptors were maintained in DMEM supplemented with 5% FBS and 5% CBS, penicillin/streptomycin, and puromycin (2 g/ml). ACII/D2L, ACII/ D3, and ACII/D4 cells were maintained in DMEM supplemented with 5% FBS and 5% CBS, penicillin/streptomycin, puromycin (2 g/ml), and hygromycin (460 units/ml). HEK-ACII cells were maintained in DMEM supplemented with 5% FBS and 5% CBS, penicillin/streptomycin, and hygromycin (460 units/ml). Cells were grown in a humidified incubator at 37°in the presence of 10% CO 2 .
cAMP accumulation assays. Cells were plated at densities between 100,000 and 150,000 cells/well in 48-well tissue culture clusters. Confluent cells were preincubated with 200 l of assay buffer (Earle's balanced salt solution, containing 0.02% ascorbic acid and 2% CBS) for 10 min, then placed on ice. All drugs were added at 4°, then each cluster was transferred to a 37°water bath. After 15 min, the medium was decanted, and the cells were placed on ice and lysed with 3% trichloroacetic acid. The 48-well plates were then stored at 4°for at least 1 hr and centrifuged at 1000 ϫ g for 15 min before quantification of cAMP. For pertussis toxin experiments, the toxin was added to the growth medium (25 ng/ml) 18 hr before the cAMP accumulation assay. This treatment has been determined to eliminate detectable coupling of D 2 dopamine receptors to inhibition of cAMP accumulation (22) .
Quantification of cAMP. cAMP was quantified using a competitive binding assay adapted with minor modifications from Nordstedt and Fredholm (23) . Duplicate samples of the cell lysate (10-20 l) were added to reaction tubes containing cAMP assay buffer (100 mM Tris/HCl, pH, 7.4, 100 mM NaCl, 5 mM EDTA). [ 3 H]cAMP (1 nM final concentration) was added to each tube, followed by cAMP-binding protein ( ‫001ف‬ g of crude extract from bovine adrenal cortex in 200 l of cAMP buffer). The reaction tubes were incubated on ice for 3 hr. The tubes were then harvested by filtration (Whatman GF/C filters) using a 96-well Tomtec cell harvester. Filters were allowed to dry, and BetaPlate scintillation fluid (50 l) was added to each sample. Radioactivity on the filters was determined using an Wallac BetaPlate scintillation counter. The concentration of cAMP in each sample was estimated in duplicate assays from a standard curve ranging from 0.1 to 100 pmol cAMP/assay.
Data analysis. Dose-response curves for cAMP were analyzed by nonlinear regression using the program Prism 2.0 (GraphPad Software, San Diego, CA). Statistical comparisons were made using ANOVA followed by Dunnett's post hoc t test comparing control with drug groups, except where indicated in the figure legends.
Results and Discussion
We examined cAMP accumulation in HEK 293 cells expressing only the D 2L receptor. HEK-D 2L cells were treated with isoproterenol (100 nM) or PMA (100 nM) in the absence or presence of dopamine (1 M) or quinpirole (1 M), and cAMP accumulation was determined. There was no significant stimulation of cAMP accumulation above basal levels by isoproterenol (100 nM) or PMA (100 nM), reflecting the low level of adenylate cyclase activity that has made the HEK 293 cell line valuable for the characterization of recombinant adenylate cyclases (24) (data not shown). We also examined cAMP accumulation in HEK 293 cells expressing ACII (HEK-ACII). We found that isoproterenol acting via endogenously expressed ␤-adrenergic receptors stimulated cAMP accumulation 3-fold above basal levels in HEK-ACII cells (data not shown). PMA, which is thought to bypass G s and activate ACII by protein kinase C-dependent phosphorylation of the enzyme (12) , stimulated cAMP accumulation 40-fold above basal levels in HEK-ACII cells (data not shown). The D 2 agonists, quinpirole or dopamine, had no effect on isoproterenol-or PMA-stimulated cAMP accumulation in HEK-ACII cells (data not shown). However, when cAMP accumulation is stimulated by forskolin in HEK-D 2L cells, activation of D2L receptors inhibits cAMP accumulation (22) . of ␣ s (100 nM isoproterenol), there was marked potentiation of isoproterenol-stimulated cAMP accumulation ( Fig. 1 and Table 1 ). This potentiation seemed to be mediated via D 2L receptors acting through a G i/o protein because it was blocked by the D 2 antagonist, spiperone, and by pretreatment of the cells with pertussis toxin (25 ng/ml for 18 hr; Table 1 ). The effect of dopamine on isoproterenol-stimulated cAMP accumulation was dose-dependent, with an EC 50 value of 32 nM ( (Fig. 1) , and the effects were blocked by spiperone or by pretreatment with pertussis toxin (Table 1) . Staurosporine did not prevent the D 2 -like receptor potentiation of isoproterenol-stimulated activity, indicating that the potentiation is not mediated by dopamine receptor activation of protein kinase C (Table 1) . In contrast to the effects of D 2L and D 4.4 receptors, activation of D 3 receptors was without effect on cAMP accumulation (Fig. 1) . The lack of a D 3 -mediated effect does not seem to be due to low receptor density. Although the ACII/D2L and ACII/D4 cells had receptor densities of 600 and 1500 fmol/mg of membrane protein, respectively, we tested nine ACII/D3 clones ranging in receptor density from 200-1300 fmol/mg of protein, and none produced significant potentiation of isoproterenol-stimulated cAMP accumulation in the presence of dopamine agonists (data not shown). The data presented in Figs The results of the studies with ACII/D2L and ACII/D4 cells are consistent with studies demonstrating that stimulation of G i/o -coupled receptors, in combination with activation of ␣ s (via G s -coupled receptors or co-transfection with a constitutively active ␣ s , ␣ s -Q227L), stimulates ACII (7, 9, 15, 16). The activation of G i/o -coupled receptors releases ␤␥ subunits, which in turn potentiate the activation of ACII by ␣ s . The role of ␤␥ subunits is supported by the observation that co-expression of ␣ t , which presumably sequesters released ␤␥ subunits, blocks activation of ACII by G i/o -coupled receptors (7, 9, 17, 19) . Moreover, reconstitution studies indicate that ACII is directly stimulated by ␤␥ subunits in combination with activated ␣ s (11, 13) and also by ␤␥ subunits alone, albeit to a lesser extent (13) . The ␣ subunits of G i/o do not directly modulate ACII, because transfection of constitutively active mutants of these ␣ subunits has little effect on basal or receptor-stimulated activity of ACII in HEK 293 cells (9) . D 2 dopaminergic and ␣ 2 -adrenergic receptors are among the G i/o -coupled receptors that activate ACII, but they differ in their mode of activation (7) . Unlike the D 2 receptor, the ␣ 2 -adrenergic receptor stimulates ACII in the absence of constitutively active ␣ s -Q227L. It has been suggested that the ability of the ␣ 2 -adrenergic receptor to couple to G s is responsible for this difference between the two receptors (7). Consistent with this suggestion, the activation of ACII by D 2 receptors was abolished by pretreatment with pertussis toxin, whereas the activation by ␣ 2 -adrenergic receptors was not (7) . In the present study, we have confirmed the finding that potentiation of G s -stimulated cAMP accumulation by D 2L receptors is blocked by pretreatment with pertussis toxin and have extended this observation to the D 4.4 receptor. (12) . Furthermore, short term PMA treatment of intact cells does not activate ␣ s , as assessed by reconstituted adenylate cyclase activity in the membranes of S49 cyc Ϫ cells (25) . To examine the hypothesis that ␤␥ subunits released by the activation of G i/o -coupled receptors can potentiate the actions of protein kinase C on ACII, we assessed the ability of dopamine agonists to enhance PMA-stimulated cAMP accumulation in ACII/D2L, ACII/D3, and ACII/D4 cells. When stimulation by PMA (100 nM) was conducted in the presence of dopamine (1 M) or quinpirole (1 M), cAMP accumulation was 2-4-fold greater, compared with PMA alone, indicating that D 2 agonists potentiated the actions of PMA in ACII/D2L cells ( Fig. 3 and Table 2 ). The effects of D 2 agonists on PMA-stimulated cAMP accumulation were blocked by co-incubation with spiperone (1 M) and by overnight treatment with pertussis toxin (Table 2). Analysis of dose response curves revealed that the potentiation by dopamine was dose-dependent, with an EC 50 value of 132 nM (Fig. 2) . Similarly, activation of D 4.4 receptors potentiated PMA-stimulated cAMP accumulation in ACII/D4 cells, and this effect was blocked by spiperone and by pretreatment with pertussis toxin (Fig. 3 and Table 2 ). The effect of D 4.4 receptor activation on PMA-stimulated cAMP accumulation was also blocked by the D 4 antagonist clozapine (data not shown). We also observed that pertussis toxintreatment significantly reduced PMA-stimulated cAMP accumulation in ACII/D2L and ACII/D4 cells. There was also a trend for spiperone to decrease PMA-stimulated activity in both cell lines (Table 2) , and to decrease isoproterenol-stimulated activity in ACII/D4 cells (Table 1) . These results may reflect constitutive activity of the D 2 -like receptors and further suggest that spiperone is an inverse agonist at these receptors.
In contrast to the ability of D 2 and D 4 receptors to potentiate cAMP accumulation, D 3 receptor activation did not augment PMA-stimulated cAMP accumulation in ACII/D3 cells (Fig. 3) . One difference between the current study and that of Tsu and Wong (19) is that in the latter study the cells were pretreated with PMA before addition of dopamine agonists.
In an effort to demonstrate modulation of ACII by D 3 receptors, we also completed studies in which ACII/D3 cells were pretreated with PMA for 10 min before ACII stimulation in the presence of dopamine agonists. These studies demonstrated that pretreatment with PMA significantly enhanced basal and stimulated (isoproterenol and PMA) ACII activity, but there was no potentiation of cAMP accumulation by dopamine agonists in ACII/D3 cells (data not shown).
The finding that D 2L receptor activation potentiates cAMP accumulation stimulated by either ␣ s (i.e., isoproterenol) or protein kinase C (PMA) in a pertussis toxin-sensitive manner strongly suggests that activated ␣ s is not an absolute requirement for stimulation of ACII by ␤␥ subunits, but that the binding of ␤␥ subunits to ACII enhances the effects of other activators. In studies with ACII/D2L and ACII/D4 cells, the protein kinase C inhibitor, staurosporine, abolished both PMA-stimulated ACII activity and the potentiation of that pathway by dopamine agonists (Table 2) , further indicating that the activation of ACII by ␤␥ subunits requires co-activation of the protein kinase C pathway. PMA activation of ACII was enhanced by ␤␥ subunits in both ACII/D2L and ACII/D4 cells, but not in ACII/D3 cells.
The current study adds another divergent signaling pathway to the D 2 -like dopamine receptor family. The results of these studies are similar to those examining D 2 , D 3 , and D 4 -mediated inhibition of cAMP accumulation in which D 2 and D 4 receptors display robust inhibition and D 3 receptors show little or no effect (2-4). Thus, it seems that the inefficient coupling of D 3 receptors to G i/o proteins provides a (29) . Thus, in Ltk Ϫ fibroblasts expressing ACII and D 2 receptors, it is possible that D 2 agonists could stimulate cAMP accumulation due to increased protein kinase C activity in combination with the release of ␤␥ subunits from G i/o . The protein kinase C pathway has also been implicated in D 2 receptor-potentiated arachadonic acid release in Chinese hamster ovary cells and in inhibition of cell proliferation in GH 4 ZR 7 cells, because inhibitors of protein kinase C block both of these D 2 receptor effects (30, 31) . Taken together, these observations and the current study suggest that the interactions between the protein kinase C pathway and D 2 dopamine receptors are important in modulating neurotransmission in a variety of cell types.
In summary, we have demonstrated that activation of D 2L and D 4.4 receptors potentiated isoproterenol-and PMA-stimulated cAMP synthesis by ACII, whereas D 3 receptors did not. Furthermore, our data confirm that ACII can be synergistically activated by multiple signals, including PMA and ␤␥ subunits, ␣ s and ␤␥ subunits, or PMA and ␣ s . However, the activation of ACII by ␤␥ subunits is conditional, requiring co-activation by either protein kinase C or ␣ s , suggesting that the binding of ␤␥ to ACII results in an enhancement of responsiveness of the enzyme to other activators. Potentiation of PMA-stimulated ACII activity by ␤␥ subunits represents another example of coincident signal detection and may influence the interactions between D 2L and D 4.4 dopamine receptors and the protein kinase C pathway. 
